Details

Autor(en) / Beteiligte

• Dasgupta, Kaberi, MD, MSc
• Quinn, Robert R., MD, PhD
• Zarnke, Kelly B., MD, MSc
• Rabi, Doreen M., MD, MSc
• Ravani, Pietro, MD, PhD
• Daskalopoulou, Stella S., MD, PhD
• Rabkin, Simon W., MD
• Trudeau, Luc, MD
• Feldman, Ross D., MD
• Cloutier, Lyne, RN, PhD
• Prebtani, Ally, MD
• Herman, Robert J., MD
• Bacon, Simon L., PhD
• Gilbert, Richard E., MD, PhD
• Ruzicka, Marcel, MD, PhD
• McKay, Donald W., PhD
• Campbell, Tavis S., PhD
• Grover, Steven, MD, MPA
• Honos, George, MD
• Schiffrin, Ernesto L., MD, PhD
• Bolli, Peter, MD
• Wilson, Thomas W., MD
• Lindsay, Patrice, RN, PhD
• Hill, Michael D., MD, MSc
• Coutts, Shelagh B., MD
• Gubitz, Gord, MD
• Gelfer, Mark, MD
• Vallée, Michel, MD, PhD
• Prasad, G.V. Ramesh, MBBS, MSc
• Lebel, Marcel, MD
• McLean, Donna, RN, NP, PhD
• Arnold, J. Malcolm O., MD
• Moe, Gordon W., MD, MSc
• Howlett, Jonathan G., MD
• Boulanger, Jean-Martin, MD
• Larochelle, Pierre, MD
• Leiter, Lawrence A., MD
• Jones, Charlotte, MD, PhD
• Ogilvie, Richard I., MD
• Woo, Vincent, MD
• Kaczorowski, Janusz, PhD
• Burns, Kevin D., MD
• Petrella, Robert J., MD, PhD
• Hiremath, Swapnil, MD, MPH
• Milot, Alain, MD, MSc
• Stone, James A., MD, PhD
• Drouin, Denis, MD
• Lavoie, Kim L., PhD
• Lamarre-Cliche, Maxime, MD
• Tremblay, Guy, MD
• Hamet, Pavel, MD, PhD
• Fodor, George, MD, PhD
• Carruthers, S. George, MD
• Pylypchuk, George B., MD
• Burgess, Ellen, MD
• Lewanczuk, Richard, MD, PhD
• Dresser, George K., MD, PhD
• Penner, S. Brian, MD
• Hegele, Robert A., MD
• McFarlane, Philip A., MD, PhD
• Khara, Milan, MBChB
• Pipe, Andrew, CM, MD
• Oh, Paul, MD, MSc
• Selby, Peter, MBBS, MHSc
• Sharma, Mukul, MD, MSc
• Reid, Debra J., PhD, RD
• Tobe, Sheldon W., MD, MSc(HPTE)
• Padwal, Raj S., MD, MSc
• Poirier, Luc, BPharm, MSc

Titel

The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Ist Teil von

• Canadian journal of cardiology, 2014-05, Vol.30 (5), p.485-501

Ort / Verlag

England: Elsevier Inc

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract Herein, updated evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in Canadian adults are detailed. For 2014, 3 existing recommendations were modified and 2 new recommendations were added. The following recommendations were modified: (1) the recommended sodium intake threshold was changed from ≤ 1500 mg (3.75 g of salt) to approximately 2000 mg (5 g of salt) per day; (2) a pharmacotherapy treatment initiation systolic blood pressure threshold of ≥ 160 mm Hg was added in very elderly (age ≥ 80 years) patients who do not have diabetes or target organ damage (systolic blood pressure target in this population remains at < 150 mm Hg); and (3) the target population recommended to receive low-dose acetylsalicylic acid therapy for primary prevention was narrowed from all patients with controlled hypertension to only those ≥ 50 years of age. The 2 new recommendations are: (1) advice to be cautious when lowering systolic blood pressure to target levels in patients with established coronary artery disease if diastolic blood pressure is ≤ 60 mm Hg because of concerns that myocardial ischemia might be exacerbated; and (2) the addition of glycated hemoglobin (A1c) in the diagnostic work-up of patients with newly diagnosed hypertension. The rationale for these recommendation changes is discussed. In addition, emerging data on blood pressure targets in stroke patients are discussed; these data did not lead to recommendation changes at this time. The Canadian Hypertension Education Program recommendations will continue to be updated annually.